Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Erratum

Erratum 32 Mulay K, Ali MJ, Reddy VA, Honavar SG: Or- 37 Taddesse-Heath L, Meloni-Ehrig A, Scheerle 43 Chabay P, De Matteo P, Lorenzetti M, Gutier- bital plasmablastic lymphoma: a clinico-path- J, Kelly JC, et al: Plasmablastic lymphoma rez M, et al: Vulvar plasmablastic lymphoma ological correlation of a rare disease and re- with MYC translocation: evidence of a com- in a HIV-positive child: a novel extra-oral lo- view of literature. Clin Ophthalmol 2012; 6: mon pathway in the generation of plasma- calization. J Clin Pathol 2009; 62: 644–646. 2049–2057. blastic features. Mod Pathol 2010; 23: 991– 44 Ojanguren J, Collazos J, Martinez C, Alvarez 33 Kim JE, Kim YA, Kim WY, Kim CW, et al: 999. J, et al: Epstein-Barr virus related plasmablas- Human immunodeficiency virus-negative 38 Lin Y, Rodriguez GD, Turner JF, Vasef MA, tic lymphomas arising from long-standing sa- plasmablastic lymphoma in Korea. Leuk et al: Plasmablastic lymphoma of the lung. crococcygeal cysts in immunosuppressed pa- Lymphoma 2009; 50: 582–587. Arch Pathol Lab Med 2001; 125: 282–285. tients. AIDS 2003; 17: 1582–1584. 34 Valenzuela AA, Walker NJ, Sullivan TJ: Plas- 39 Masgala A, Christopoulos C, Giannakou N, 45 Takahashi Y, Saiga I, Fukushima J, Seki N, et mablastic lymphoma in the orbit: case report. Boukis H, et al: Plasmablastic lymphoma of al: Plasmablastic lymphoma of the retroperi- Orbit 2008; 27: 227–229. the visceral cranium, cervix and thorax in an toneum in an HIV-negative patient. Pathol 35 Zhang LY, Lin HY, Gao LX, Li L, et al: Pri- HIV-negative woman. Ann Hematol 2007; 86: Int 2009; 59: 868–873. mary central nervous system plasmablastic 615–618. 46 Nasta SD, Carrum GM, Shahab I, hanania lymphoma presenting in a human immuno- 40 Cha JM, Lee JI, Joo KR, Jung SW, et al: A case NA, et al: Regression of a plasmablastic lym- deficiency virus-negative but Epstein-Barr report with plasmablastic lymphoma of the phoma in a patient with HIV on highly active virus-positive patient: a case report. Diagn jejunum. J Korean Med Sci 2010; 25: 496–500. antiretroviral therapy. Leuk Lymphoma 2002; Pathol 2012; 7: 51. 41 Kravetz JD, Rose MG, Payne-Blackman S, Fe- 43: 423–426. 36 Saraceni C, Agostino N, Cornfield DB, Gupta derman DG: Plasmablastic lymphoma pre- 47 Redmond M, Quinn J, Murphy P, Patchett S, R: Plasmablastic lymphoma of the maxillary senting as an arm mass in an individual nega- et al: Plasmablastic lymphoma presenting as a sinus in an HIV-negative patient: a case re- tive for human immunodeficiency virus: a paravertebral mass in a patient with Crohn’s port and literature review. SpringerPlus 2013; case report. Clin Lymphoma Myeloma 2006; disease after immunosuppressive therapy. J 2: 142. 6: 493–495. Clin Pathol 2007; 60: 80–81. 42 Mondal SK, Bera H, Biswas PK, Mallick MG: High-grade plasmablastic neoplasm of hu- merus in an HIV-negative patient, which was indeterminate between plasmablastic lym- phoma and plasmablastic myeloma. J Can Res Ther 2011; 7: 214–216. In the article by Davis Davey D, Goulart R, Nayar R, on behalf of the Cytopathology Educa- tion and Technology Consortium (CETC), entitled ‘2013 statement on human papilloma- virus DNA test utilization’ [Acta Cytologica 2014;58:113–116, DOI: 10.1159/000358795], the authors wish to correct the title and text to remove the word ‘DNA’, as the statement also allows for use of any clinically validated HPV testing method. One RNA testing meth- od is now approved by the Food and Drug Administration in addition to several DNA test- ing methods. Most of the studies that supported the previous HPV test guidelines involved DNA testing, but it is recognized that other molecular testing methods have demonstrated similar performance. The title and the first sentence should include the words ‘human pap- illomavirus test’ instead of ‘human papillomavirus DNA test’, and statement 1 should be ‘HPV testing’ instead of ‘HPV DNA testing’. The corrected reference should read: Davis Davey D, Goulart R, Nayar R, on behalf of the Cytopathology Education and Technology Consortium (CETC): ‘2013 statement on human papillomavirus test utilization’ [Acta Cy- tologica 2014;58:113–116, DOI: 10.1159/000358795]. The authors regret this error. Acta Cytologica 2014;58:309–317 Cytology and FC of Plasmablastic 317 DOI: 10.1159/000360359 Lymphoma http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Acta Cytologica Karger

Erratum

Acta Cytologica , Volume 58 (3): 1 – Jan 1, 2014

Loading next page...
 
/lp/karger/erratum-df3nV6LIvK

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Publisher
Karger
Copyright
© 2014 S. Karger AG, Basel
ISSN
0001-5547
eISSN
1938-2650
DOI
10.1159/000362353
Publisher site
See Article on Publisher Site

Abstract

32 Mulay K, Ali MJ, Reddy VA, Honavar SG: Or- 37 Taddesse-Heath L, Meloni-Ehrig A, Scheerle 43 Chabay P, De Matteo P, Lorenzetti M, Gutier- bital plasmablastic lymphoma: a clinico-path- J, Kelly JC, et al: Plasmablastic lymphoma rez M, et al: Vulvar plasmablastic lymphoma ological correlation of a rare disease and re- with MYC translocation: evidence of a com- in a HIV-positive child: a novel extra-oral lo- view of literature. Clin Ophthalmol 2012; 6: mon pathway in the generation of plasma- calization. J Clin Pathol 2009; 62: 644–646. 2049–2057. blastic features. Mod Pathol 2010; 23: 991– 44 Ojanguren J, Collazos J, Martinez C, Alvarez 33 Kim JE, Kim YA, Kim WY, Kim CW, et al: 999. J, et al: Epstein-Barr virus related plasmablas- Human immunodeficiency virus-negative 38 Lin Y, Rodriguez GD, Turner JF, Vasef MA, tic lymphomas arising from long-standing sa- plasmablastic lymphoma in Korea. Leuk et al: Plasmablastic lymphoma of the lung. crococcygeal cysts in immunosuppressed pa- Lymphoma 2009; 50: 582–587. Arch Pathol Lab Med 2001; 125: 282–285. tients. AIDS 2003; 17: 1582–1584. 34 Valenzuela AA, Walker NJ, Sullivan TJ: Plas- 39 Masgala A, Christopoulos C, Giannakou N, 45 Takahashi Y, Saiga I, Fukushima J, Seki N, et mablastic lymphoma in the orbit: case report. Boukis H, et al: Plasmablastic lymphoma of al: Plasmablastic lymphoma of the retroperi- Orbit 2008; 27: 227–229. the visceral cranium, cervix and thorax in an toneum in an HIV-negative patient. Pathol 35 Zhang LY, Lin HY, Gao LX, Li L, et al: Pri- HIV-negative woman. Ann Hematol 2007; 86: Int 2009; 59: 868–873. mary central nervous system plasmablastic 615–618. 46 Nasta SD, Carrum GM, Shahab I, hanania lymphoma presenting in a human immuno- 40 Cha JM, Lee JI, Joo KR, Jung SW, et al: A case NA, et al: Regression of a plasmablastic lym- deficiency virus-negative but Epstein-Barr report with plasmablastic lymphoma of the phoma in a patient with HIV on highly active virus-positive patient: a case report. Diagn jejunum. J Korean Med Sci 2010; 25: 496–500. antiretroviral therapy. Leuk Lymphoma 2002; Pathol 2012; 7: 51. 41 Kravetz JD, Rose MG, Payne-Blackman S, Fe- 43: 423–426. 36 Saraceni C, Agostino N, Cornfield DB, Gupta derman DG: Plasmablastic lymphoma pre- 47 Redmond M, Quinn J, Murphy P, Patchett S, R: Plasmablastic lymphoma of the maxillary senting as an arm mass in an individual nega- et al: Plasmablastic lymphoma presenting as a sinus in an HIV-negative patient: a case re- tive for human immunodeficiency virus: a paravertebral mass in a patient with Crohn’s port and literature review. SpringerPlus 2013; case report. Clin Lymphoma Myeloma 2006; disease after immunosuppressive therapy. J 2: 142. 6: 493–495. Clin Pathol 2007; 60: 80–81. 42 Mondal SK, Bera H, Biswas PK, Mallick MG: High-grade plasmablastic neoplasm of hu- merus in an HIV-negative patient, which was indeterminate between plasmablastic lym- phoma and plasmablastic myeloma. J Can Res Ther 2011; 7: 214–216. In the article by Davis Davey D, Goulart R, Nayar R, on behalf of the Cytopathology Educa- tion and Technology Consortium (CETC), entitled ‘2013 statement on human papilloma- virus DNA test utilization’ [Acta Cytologica 2014;58:113–116, DOI: 10.1159/000358795], the authors wish to correct the title and text to remove the word ‘DNA’, as the statement also allows for use of any clinically validated HPV testing method. One RNA testing meth- od is now approved by the Food and Drug Administration in addition to several DNA test- ing methods. Most of the studies that supported the previous HPV test guidelines involved DNA testing, but it is recognized that other molecular testing methods have demonstrated similar performance. The title and the first sentence should include the words ‘human pap- illomavirus test’ instead of ‘human papillomavirus DNA test’, and statement 1 should be ‘HPV testing’ instead of ‘HPV DNA testing’. The corrected reference should read: Davis Davey D, Goulart R, Nayar R, on behalf of the Cytopathology Education and Technology Consortium (CETC): ‘2013 statement on human papillomavirus test utilization’ [Acta Cy- tologica 2014;58:113–116, DOI: 10.1159/000358795]. The authors regret this error. Acta Cytologica 2014;58:309–317 Cytology and FC of Plasmablastic 317 DOI: 10.1159/000360359 Lymphoma

Journal

Acta CytologicaKarger

Published: Jan 1, 2014

There are no references for this article.